Charles Schwab Investment Management Inc Renovo Rx, Inc. Put Options Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RNXT
# of Institutions
21Shares Held
2MCall Options Held
0Put Options Held
0-
Bank Of The West975KShares$916,5000.27% of portfolio
-
Geode Capital Management, LLC Boston, MA236KShares$221,6030.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX197KShares$185,4150.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA141KShares$132,9970.0% of portfolio
-
Nixon Peabody Trust CO Boston, MA97.2KShares$91,3350.01% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $8.52M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...